Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Dent
Developing a Prediction Model for Benefit From Fulvestrant in Heavily Pretreated Metastatic Breast Cancer Patients
Breast Cancer Research
Cancer Research
Oncology
Related publications
Nivolumab in Heavily Pretreated Metastatic Gastric Cancer Patients: Real-Life Data From a Western Population
OncoTargets and Therapy
Oncology
Pharmacology
Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer
Frontiers in Oncology
Cancer Research
Oncology
Fulvestrant: A Further Treatment Option for Patients With Metastatic Uterine Cancer?
Oncology Research and Treatment
Cancer Research
Oncology
Hematology
Correction To: Unexpected Benefit From Alpelisib and Fulvestrant in a Woman With Highly Pre-Treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer
Clinical Drug Investigation
Medicine
Pharmacology
Fulvestrant Treatment Is Associated With Cholesterol Plasma Level Reduction in Hormone Receptor-Positive Metastatic Breast Cancer Patients
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Pcn349 - Can We Apply the Utility Prediction Mathematical Model for Recurrent Metastatic Breast Cancer to Japanese Patients?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
More Breast Cancer Patients Could Benefit From PARP Inhibitors
Cancer
Cancer Research
Oncology
Prediction of Metastatic Damage of Regional Lymphatic Nodes in Patients With Breast Cancer
Tumors of female reproductive system
Mitomycin C and High-Dose 5-Fluorouracil With Folinic Acid as a Therapeutic Option for Heavily Pretreated Patients With Metastatic Colorectal Cancer: Prospective Phase II Trial
Oncologist
Cancer Research
Medicine
Oncology
